新葡京平台

 
Glories

 

1992

The company was established.

2003

The company increased its registered capital to RMB 30 million.

2003

Our chick embryo freeze-dried vaccine production line and cells freeze-dried vaccine production line in active vaccine production workshop and chick embryo vaccine production line in inactivated vaccine production workshop passed the National GHP Dynamic Acceptance.

2004

The company was designated as one of national avian influenza vaccine manufacturers to produce avian influenza inactivated vaccine (H5 subtype, N28 strain) and transferred its vaccine technology to other seven domestic veterinary biochemical factories.

2005

Our virus tissue inactivated vaccine production line and cell inactivated vaccine production line in inactivated vaccine production workshop passed the National GHP Dynamic Acceptance.

2005

Our 37 products obtained the National Approval Numbers.

2005

The company produced the recombinant avian influenza virus inactivated vaccine (H5N1 subtype, Re-1 strain), which is in consistence with domestic popular strains, making an outstanding contribution to fight against domestic avian influenza.

2005

H5 subtype avian influenza inactivated vaccine was exported to Vietnam, making a contribution to control the pestilence globally.

2005

The company was identified as “Heilongjiang High-tech Enterprise”.

2008

The company produced virus active vaccine (CH-lR strain) for preventing high pathogenic blue-ear disease-porcine reproductive and respiratory syndrome.

2008

The Avian Influenza Vaccine Antigen Storage was established in our company.

2008

The Veterinary Biological Products High-tech Industrialization Demonstration Base relying on our company was completed.

Webpage Copyright(c)2013-2016   en.hvriwk       Powered by:

Harbin Weike Biotechnology Development Company
Address:No.680 Haping Road Xiangfang District,Harbin,China
Service Tel: +86-451-51661188
Fax: +86-451-51661114
Email:
marketing@hvri.ac.cn  jane8878@sohu.com